Literature DB >> 22009734

B-1 cells in the bone marrow are a significant source of natural IgM.

Youn Soo Choi1, Jacquelyn A Dieter, Kristina Rothaeusler, Zheng Luo, Nicole Baumgarth.   

Abstract

Natural IgM antibodies secreted in the absence of antigenic challenge are important contributors to antimicrobial immunity and tissue homeostasis. Early studies identified BM and, to a lesser extent the spleen, as main tissue sources of this spontaneously secreted IgM. However, the responsible B-cell subset has never been identified. Using multicolor flow cytometry, cell sorting and chimeric mice in which B-1 and B-2 cells and their secreted antibodies are distinguished by their Ig-allotype, we unequivocally identify the natural IgM-secreting cells in spleen and, for the first time, in the BM as IgM(+) IgD(lo/-) CD19(hi) CD43(+) CD5(+/-) B-1 cells. The newly identified population of BM B-1 cells shows many of the phenotypic characteristics of splenic B-1 cells but is distinct from B-1 cells in the peritoneal cavity, which generate at best very small amounts of IgM. Antibody-secreting spleen and BM B-1 cells are distinct also from terminally differentiated plasma cells generated from antigen-induced conventional B cells, as they express high levels of surface IgM and CD19 and lack expression of CD138. Overall, these data identify populations of non-terminally differentiated B-1 cells in spleen and BM as the most significant producers of natural IgM.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009734      PMCID: PMC3426357          DOI: 10.1002/eji.201141890

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  56 in total

1.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

Authors:  H Masmoudi; T Mota-Santos; F Huetz; A Coutinho; P A Cazenave
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 2.  B-1 cells: unique origins and functions.

Authors:  A M Stall; S M Wells; K P Lam
Journal:  Semin Immunol       Date:  1996-02       Impact factor: 11.130

3.  Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies.

Authors:  W Parker; K Lundberg-Swanson; Z E Holzknecht; J Lateef; S A Washburn; S J Braedehoeft; J L Platt
Journal:  Hum Immunol       Date:  1996-02       Impact factor: 2.850

4.  Feedback regulation of murine Ly-1 B cell development.

Authors:  P A Lalor; L A Herzenberg; S Adams; A M Stall
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

5.  CD5+ peritoneal B cells express high levels of membrane, but not secretory, C mu mRNA.

Authors:  T M McIntyre; K L Holmes; A D Steinberg; D L Kastner
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

6.  CD43 (S7) expression identifies peripheral B cell subsets.

Authors:  S M Wells; A B Kantor; A M Stall
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

7.  Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice.

Authors:  I Förster; K Rajewsky
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

8.  Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity.

Authors:  F G Kroese; E C Butcher; A M Stall; P A Lalor; S Adams; L A Herzenberg
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

9.  Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice.

Authors:  S Nisitani; T Tsubata; M Murakami; T Honjo
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

10.  Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse.

Authors:  M Murakami; T Tsubata; R Shinkura; S Nisitani; M Okamoto; H Yoshioka; T Usui; S Miyawaki; T Honjo
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  89 in total

Review 1.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

2.  B-1a Cells Protect Mice from Sepsis: Critical Role of CREB.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

3.  Noncoordinate expression of J-chain and Blimp-1 define nurse shark plasma cell populations during ontogeny.

Authors:  Caitlin D Castro; Yuko Ohta; Helen Dooley; Martin F Flajnik
Journal:  Eur J Immunol       Date:  2013-08-27       Impact factor: 5.532

4.  Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response.

Authors:  Emilie K Grasset; Amanda Duhlin; Hanna E Agardh; Olga Ovchinnikova; Thomas Hägglöf; Mattias N Forsell; Gabrielle Paulsson-Berne; Göran K Hansson; Daniel F J Ketelhuth; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 5.  B cells and atherosclerosis.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

6.  Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture.

Authors:  Nicole Baumgarth; Elizabeth E Waffarn; Trang T T Nguyen
Journal:  Ann N Y Acad Sci       Date:  2015-06-09       Impact factor: 5.691

7.  Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.

Authors:  Ying-Yu Wu; Ina Georg; Alejandro Díaz-Barreiro; Nieves Varela; Bernard Lauwerys; Ramesh Kumar; Harini Bagavant; Mireia Castillo-Martín; Fadi El Salem; Concepción Marañón; Marta E Alarcón-Riquelme
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

8.  Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.

Authors:  Aditi Upadhye; Prasad Srikakulapu; Ayelet Gonen; Sabrina Hendrikx; Heather M Perry; Anh Nguyen; Chantel McSkimming; Melissa A Marshall; James C Garmey; Angela M Taylor; Timothy P Bender; Sotirios Tsimikas; Nichol E Holodick; Thomas L Rothstein; Joseph L Witztum; Coleen A McNamara
Journal:  Circ Res       Date:  2019-09-24       Impact factor: 17.367

9.  Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation.

Authors:  Elizabeth E Waffarn; Christine J Hastey; Neha Dixit; Youn Soo Choi; Simon Cherry; Ulrich Kalinke; Scott I Simon; Nicole Baumgarth
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919

10.  Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies.

Authors:  Thomas A Prohaska; Xuchu Que; Cody J Diehl; Sabrina Hendrikx; Max W Chang; Kristen Jepsen; Christopher K Glass; Christopher Benner; Joseph L Witztum
Journal:  J Immunol       Date:  2018-01-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.